Health ❯ Healthcare ❯ Pharmaceuticals

Medications

GLP-1 Drugs Semaglutide Weight Loss GLP-1 Receptor Agonists Obesity Treatments Wegovy Weight Loss Drugs Tirzepatide Diabetes Alzheimer's Disease

Anvisa Approves Second Generic Semaglutide in Brazil

Germed's registration creates a synthetic, lower-cost alternative that could cut consumer prices for diabetes treatment.

Foundayo Oral GLP‑1 Goes On Sale In UK Pharmacies

Anvisa Approves First Brazil-Made Generic Semaglutide and a Similar Product

Brazil Says It Has Lowest Malaria Case Rate Since 1978

UK Regulator Approves Eli Lilly’s Foundayo Tablet for Weight Loss and Type 2 Diabetes

UK Regulator Authorizes Foundayo, an Oral Once‑Daily GLP‑1 Pill

FDA Approves Orzeyful as First Orexin Agonist for Narcolepsy Type 1

Retailers Move to Fill $50 Medicare GLP‑1 Prescriptions

Anvisa Registers Five New Semaglutide Pens

NHS to Offer Fampridine to Thousands With Multiple Sclerosis

Novartis Returns to Sales Growth as New Drugs Offset Entresto Slump

FDA Approves Lipfendra, First Oral PCSK9 Pill for High LDL Cholesterol

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL

Purified THC‑CBD Drug Cuts Agitation in End‑of‑Life Dementia, Trial Shows

Wegovy Pill Hits UK Private Market as Safety and Access Worries Rise

Brazilian-Made Semaglutide Pen Ozivy Now on Sale

Employers and Insurers Pull Back Coverage for GLP‑1 Weight‑Loss Drugs

Large Observational Studies Link GLP‑1 Drugs to Lower Cancer Rates and Slower Progression